Ak. Berger et al., Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (The Cooperative Cardiovascular Project), AM J CARD, 87(3), 2001, pp. 272-277
Citations number
30
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Using data from a retrospective cohort study of Medicare beneficiaries hosp
italized with an acute myocardial infarction (AMI), we evaluated the role o
f diabetes mellitus on 30-day and 1-year mortality. We classified subjects
as nondiabetics, diabetics controlled with diet alone, diabetics receiving
an oral hypoglycemic agent, and diabetics on insulin at time of admission.
We compared baseline admission characteristics of subgroups using chi-squar
e and Wilcoxon rank-sum tests and evaluated the effect of each diabetic sta
te using sequential logistic models. We identified 80,832 nondiabetic patie
nts, 9,862 diet-controlled diabetic patients, 14,664 diabetics receiving an
oral hypoglycemic agent, and 12,241 diabetic patients on insulin therapy.
Although mean age was similar among the groups, prevalence of hypertension,
prior AMI, prior congestive heart failure, and prior revascularization wer
e higher among diabetic patients, particularly those taking insulin. Diabet
ic patients, particularly those taking insulin, were less likely to receive
aspirin and beta blockers and to undergo coronary revascularization. Diabe
tic patients had higher 30-day and 1-year mortality than nondiabetic patien
ts. After adjustment for demographics, clinical and hospital characteristic
s, and treatment strategies, insulin-treated diabetics had the highest risk
of mortality, followed by diabetics receiving oral hypoglycemic agents, fo
llowed by diet-controlled diabetics. Thus, diabetes is highly prevalent amo
ng elderly patients with an AMI. Mortality rates for these patients, partic
ularly insulin-using diabetics, are higher than among their nondiabetic cou
nterparts. Preventive and therapeutic strategies must be developed to ensur
e improved short- and long-term outcomes for elderly patients with diabetes
and AMI. (C) 2001 by Excerpta Medico, Inc.